Arvinas, Inc. (ARVN)
USD 6.2
(-5.49%)
USD 6.2
(-5.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -394.8 Million USD | -50.0% |
| 2022 | -256.89 Million USD | -34.77% |
| 2021 | -183.6 Million USD | -56.42% |
| 2020 | -117.6 Million USD | -142.33% |
| 2019 | -67.95 Million USD | -17.63% |
| 2018 | -40.71 Million USD | -85.15% |
| 2017 | -23.65 Million USD | -69.6% |
| 2016 | -13.93 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -81.6 Million USD | 50.12% |
| 2024 Q2 | -46.8 Million USD | 42.65% |
| 2024 Q3 | -58.7 Million USD | -28.85% |
| 2023 FY | - USD | -50.0% |
| 2023 Q3 | -73.9 Million USD | 0.94% |
| 2023 Q4 | -163.6 Million USD | -121.38% |
| 2023 Q1 | -87.7 Million USD | -16.31% |
| 2023 Q2 | -74.6 Million USD | 14.94% |
| 2022 Q3 | -65.1 Million USD | 1.96% |
| 2022 FY | - USD | -34.77% |
| 2022 Q4 | -75.4 Million USD | -15.82% |
| 2022 Q2 | -66.4 Million USD | -14.68% |
| 2022 Q1 | -57.9 Million USD | -6.43% |
| 2021 Q2 | -48.8 Million USD | -23.57% |
| 2021 Q1 | -39.49 Million USD | 8.61% |
| 2021 Q4 | -54.4 Million USD | -20.27% |
| 2021 Q3 | -45.23 Million USD | 7.32% |
| 2021 FY | - USD | -56.42% |
| 2020 FY | - USD | -142.33% |
| 2020 Q4 | -43.21 Million USD | -45.43% |
| 2020 Q3 | -29.71 Million USD | -22.03% |
| 2020 Q2 | -24.34 Million USD | -16.31% |
| 2020 Q1 | -20.93 Million USD | 8.14% |
| 2019 Q1 | -15.81 Million USD | 6.66% |
| 2019 FY | - USD | -17.63% |
| 2019 Q4 | -22.78 Million USD | -33.71% |
| 2019 Q3 | -17.04 Million USD | -2.4% |
| 2019 Q2 | -16.64 Million USD | -5.25% |
| 2018 Q4 | -16.94 Million USD | -28.52% |
| 2018 FY | - USD | -85.15% |
| 2018 Q1 | -3.82 Million USD | 17.26% |
| 2018 Q2 | -7.67 Million USD | -100.99% |
| 2018 Q3 | -13.18 Million USD | -71.69% |
| 2017 Q4 | -4.61 Million USD | 26.75% |
| 2017 Q3 | -6.3 Million USD | 5.0% |
| 2017 Q1 | -6.24 Million USD | 0.0% |
| 2017 Q2 | -6.63 Million USD | -6.25% |
| 2017 FY | - USD | -69.6% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -105.456% |
| Alkermes plc | 495.04 Million USD | 179.75% |
| Agenus Inc. | -145.92 Million USD | -170.552% |
| Aptorum Group Limited | -9.59 Million USD | -4012.93% |
| Ardelyx, Inc. | -55.35 Million USD | -613.228% |
| Dyadic International, Inc. | -8.22 Million USD | -4697.236% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -135570.103% |
| Lantern Pharma Inc. | -15.78 Million USD | -2400.841% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1882.685% |
| Novavax, Inc. | -487.39 Million USD | 18.997% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -455.868% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -402.975% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2096.573% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3860.674% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -588.093% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -3.903% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1537.366% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 74731.38% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -151.153% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -427.703% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1858.43% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1563.366% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1612.204% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -223.334% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -52.88% |
| AlloVir, Inc. | -190.14 Million USD | -107.63% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -124.737% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1249.375% |
| Bicycle Therapeutics plc | -183.4 Million USD | -115.267% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -138.664% |
| ChromaDex Corporation | -3.89 Million USD | -10038.675% |
| Chimerix, Inc. | -92.97 Million USD | -324.635% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -788.455% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -250.827% |
| CRISPR Therapeutics AG | -202.7 Million USD | -94.77% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1132.133% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -129.23% |
| Fortress Biotech, Inc. | -133.64 Million USD | -195.414% |
| Fortress Biotech, Inc. | -133.64 Million USD | -195.414% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -410.453% |
| ImmuCell Corporation | -2.5 Million USD | -15666.288% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -202.712% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2346.757% |
| Incyte Corporation | 919.42 Million USD | 142.94% |
| Innoviva, Inc. | 248.96 Million USD | 258.58% |
| IO Biotech, Inc. | -91.22 Million USD | -332.762% |
| Jaguar Health, Inc. | -33.13 Million USD | -1091.633% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -159.435% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 488.098% |
| ContextLogic Inc. | -324 Million USD | -21.852% |
| MiMedx Group, Inc. | 40.51 Million USD | 1074.406% |
| MEI Pharma, Inc. | 26.38 Million USD | 1596.588% |
| NextCure, Inc. | -59.03 Million USD | -568.711% |
| Onconetix, Inc. | -36.7 Million USD | -975.552% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 17764.43% |
| Opthea Limited | -200.01 Million USD | -97.381% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -14248.12% |
| Vaxcyte, Inc. | -464.88 Million USD | 15.076% |
| PDS Biotechnology Corporation | -40.08 Million USD | -884.908% |
| Precigen, Inc. | -89.22 Million USD | -342.472% |
| Pharming Group N.V. | 9.87 Million USD | 4097.165% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -148.225% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1634.47% |
| PureTech Health plc | -11.62 Million USD | -3295.545% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2224.951% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -69.081% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1537.366% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -351.577% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1263.118% |
| Acelyrin, Inc. | -381.52 Million USD | -3.479% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3063954.097% |
| Summit Therapeutics Inc. | 1 Million USD | 39540.559% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1082.532% |
| Senti Biosciences, Inc. | -61.33 Million USD | -543.668% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -251.546% |
| Elevation Oncology, Inc. | -41.46 Million USD | -852.082% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1177.505% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -6354.623% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -122890.654% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1116.529% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -4602.239% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -571.543% |
| Seer, Inc. | -97.88 Million USD | -303.33% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -534.757% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -503.993% |
| ESSA Pharma Inc. | -26.45 Million USD | -1392.328% |
| GlycoMimetics, Inc. | -39.12 Million USD | -909.151% |
| GT Biopharma, Inc. | 5.97 Million USD | 6703.111% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -91.008% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -5648.398% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 554.776% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -595.634% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -670.808% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3893.161% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 26.879% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -5635.038% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -742.474% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -66.848% |
| Aptose Biosciences Inc. | -52.26 Million USD | -655.338% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -266.426% |
| Soligenix, Inc. | -7.85 Million USD | -4927.474% |
| Century Therapeutics, Inc. | -121.2 Million USD | -225.721% |
| Kura Oncology, Inc. | -164.95 Million USD | -139.338% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -392.896% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3814.337% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -41122.087% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -9062.219% |
| Autolus Therapeutics plc | -156.77 Million USD | -151.834% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -366.352% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -472.166% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1880.536% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -108.588% |
| GRI Bio, Inc. | -10.89 Million USD | -3522.683% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8642.802% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -222.27% |
| IGM Biosciences, Inc. | -253.35 Million USD | -55.827% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -280.376% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -935.318% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2475.19% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2407.743% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -594.52% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -268.617% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -48.423% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -103.569% |
| Verastem, Inc. | -83.16 Million USD | -374.713% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -680.669% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -149.513% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -246.046% |
| Histogen Inc. | -10.5 Million USD | -3658.926% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2664.762% |
| Surrozen, Inc. | -41.13 Million USD | -859.86% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2566.487% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 12310670.627% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -572.421% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -669.681% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1732.954% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -4634.946% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -137.737% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -701.487% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1533.7% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2522.378% |
| Apollomics, Inc. | -171.74 Million USD | -129.873% |
| Amarin Corporation plc | -50.9 Million USD | -675.615% |
| Mesoblast Limited | -61.33 Million USD | -543.72% |
| Turnstone Biologics Corp. | -56.23 Million USD | -602.066% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -175.696% |
| Synaptogenix, Inc. | -8.3 Million USD | -4652.328% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2473.831% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -526.2% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8139.649% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 92119.607% |
| Exelixis, Inc. | 196.6 Million USD | 300.812% |
| Better Therapeutics, Inc. | -38.26 Million USD | -931.833% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -179.19% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 20.276% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3246.995% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 159798.401% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1238.033% |
| Gritstone bio, Inc. | -126.86 Million USD | -211.202% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -507.525% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9770.133% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3338.725% |
| Insmed Incorporated | -654.73 Million USD | 39.701% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -17448.858% |
| MediWound Ltd. | -4.89 Million USD | -7968.67% |
| OmniAb, Inc. | -49.73 Million USD | -693.871% |
| Alector, Inc. | -142.89 Million USD | -176.293% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -362.111% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -657.076% |
| Zai Lab Limited | -366.57 Million USD | -7.7% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -35.84% |
| Aura Biosciences, Inc. | -83.69 Million USD | -371.707% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -75.273% |
| Immunic, Inc. | -99.11 Million USD | -298.337% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -199.841% |
| Veracyte, Inc. | -49.4 Million USD | -699.045% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5488.956% |
| FibroGen, Inc. | -261.4 Million USD | -51.03% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3443.668% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5538.93% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2009.327% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 127.238% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1452.986% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1089.722% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1612.644% |
| Galecto, Inc. | -37.51 Million USD | -952.267% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -931.752% |
| Fortrea Holdings Inc. | 167.3 Million USD | 335.983% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -194.013% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1294.511% |
| XBiotech Inc. | -35.76 Million USD | -1003.842% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -507.525% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -505.057% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -277.962% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1437.862% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -866.061% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 23.556% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -604.736% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -704258.531% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -239.365% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1680.821% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -67.954% |
| NexImmune, Inc. | -28.16 Million USD | -1301.615% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -7044.993% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3247.955% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 108.483% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1454.82% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3270.571% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -213.717% |
| Ainos, Inc. | -8.77 Million USD | -4400.121% |
| Pluri Inc. | -20.22 Million USD | -1852.04% |
| Prothena Corporation plc | -190.1 Million USD | -107.671% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -207.961% |
| Celularity Inc. | -183.94 Million USD | -114.628% |
| Rallybio Corporation | -72.37 Million USD | -445.507% |
| Cue Biopharma, Inc. | -46.05 Million USD | -757.292% |
| MeiraGTx Holdings plc | -57.05 Million USD | -592.0% |
| Omeros Corporation | -163.61 Million USD | -141.306% |
| Humacyte, Inc. | -96.45 Million USD | -309.297% |
| Immunocore Holdings plc | -59.64 Million USD | -561.872% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1937.993% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1520.357% |
| Blueprint Medicines Corporation | -474.61 Million USD | 16.816% |
| CalciMedica, Inc. | -34.18 Million USD | -1054.757% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -439.094% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -214.589% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -134.371% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -56.425% |
| Pulmatrix, Inc. | -12.64 Million USD | -3021.936% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1097.598% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -346.268% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 22.025% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -290.061% |
| Cytokinetics, Incorporated | -456.68 Million USD | 13.551% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1082.992% |
| Nutriband Inc. | -5.12 Million USD | -7608.262% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -812.368% |
| Vor Biopharma Inc. | -114.37 Million USD | -245.192% |
| Roivant Sciences Ltd. | -996.51 Million USD | 60.382% |
| Evogene Ltd. | -23.2 Million USD | -1601.431% |
| ProKidney Corp. | -147.66 Million USD | -167.355% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -511.761% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -257688.167% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 30.182% |
| CorMedix Inc. | -48.88 Million USD | -707.576% |
| BioLineRx Ltd. | -57.06 Million USD | -591.891% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -253.263% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -195345.545% |
| Atai Life Sciences N.V. | -36.31 Million USD | -987.274% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -396.498% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -385.531% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -43.302% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1184.32% |
| MediciNova, Inc. | -9.87 Million USD | -3895.964% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -213.48% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -25700.532% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1380.383% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -75.474% |
| Biomea Fusion, Inc. | -124.62 Million USD | -216.803% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -19.513% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1415.198% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -107.419% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -71.695% |
| Absci Corporation | -95.45 Million USD | -313.589% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1214.904% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -268.566% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -69.097% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1627.412% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -89.957% |
| Allakos Inc. | -189.91 Million USD | -107.882% |
| Imunon, Inc. | -19.87 Million USD | -1886.087% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -263.898% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 464.462% |
| BioAtla, Inc. | -122.24 Million USD | -222.969% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3246.995% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2404.917% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -31.472% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -852.542% |
| XOMA Corporation | -39.36 Million USD | -902.998% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -297.767% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -235.572% |
| aTyr Pharma, Inc. | -52.17 Million USD | -656.641% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -371.037% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -165.624% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -68.312% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2791.672% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4809.043% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2249.72% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 209314.333% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 187.355% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6079.734% |
| UroGen Pharma Ltd. | -63.83 Million USD | -518.508% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -481.315% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5335.761% |
| Orgenesis Inc. | -60.71 Million USD | -550.219% |
| Entera Bio Ltd. | -8.8 Million USD | -4384.325% |
| GH Research PLC | -41.15 Million USD | -859.347% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1447.083% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -380.099% |
| Xencor, Inc. | -125.87 Million USD | -213.647% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -27575.257% |
| Replimune Group, Inc. | -230.19 Million USD | -71.505% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1858.565% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3508.116% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6079.734% |
| Portage Biotech Inc. | -18.19 Million USD | -2069.35% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -25700.532% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -277.496% |
| OncoCyte Corporation | -23.12 Million USD | -1607.391% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3393.693% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3345.977% |
| Purple Biotech Ltd. | -22.22 Million USD | -1676.378% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -6059.126% |
| scPharmaceuticals Inc. | -46.06 Million USD | -757.124% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2116.772% |
| HilleVax, Inc. | -132.46 Million USD | -198.039% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3612.969% |
| Tharimmune, Inc. | -9.3 Million USD | -4143.98% |
| Genprex, Inc. | -31.06 Million USD | -1171.065% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -110.531% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1159.169% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -51575.393% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 261723.284% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2507224.143% |
| Savara Inc. | -59.13 Million USD | -567.648% |
| Curis, Inc. | -45.13 Million USD | -774.632% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1185.93% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2498.882% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5410.119% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1376.771% |
| BeiGene, Ltd. | -1.12 Billion USD | 64.895% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2321.908% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 8.31% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -337.016% |
| Erasca, Inc. | -121.31 Million USD | -225.447% |
| bluebird bio, Inc. | -167.16 Million USD | -136.179% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8675.759% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 227.238% |
| DBV Technologies S.A. | -85.98 Million USD | -359.166% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8675.759% |
| Moderna, Inc. | -3.28 Billion USD | 87.974% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -826.565% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -6890.085% |
| Molecular Templates, Inc. | 1.43 Million USD | 27708.392% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -559.627% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -21.013% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -187.988% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -733.509% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -183.959% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -91.781% |
| MacroGenics, Inc. | 2.01 Million USD | 19673.624% |
| RenovoRx, Inc. | -11.39 Million USD | -3366.198% |
| Adicet Bio, Inc. | -136.53 Million USD | -189.157% |
| Prime Medicine, Inc. | -193.75 Million USD | -103.758% |
| Aditxt, Inc. | -25.45 Million USD | -1450.792% |
| Adagene Inc. | -14.95 Million USD | -2540.664% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5300.748% |
| Quantum-Si incorporated | -91.8 Million USD | -330.047% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 155.418% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 412.206% |
| SciSparc Ltd. | -5.28 Million USD | -7374.441% |
| Vericel Corporation | 2.86 Million USD | 13884.916% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -414571.036% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1720.074% |
| Generation Bio Co. | -133.3 Million USD | -196.174% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -375.491% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -358.947% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -73.589% |
| Invivyd, Inc. | -196.61 Million USD | -100.799% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -5.518% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4156.696% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1553.929% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3738.6% |
| 2seventy bio, Inc. | -206.41 Million USD | -91.262% |
| ADMA Biologics, Inc. | 5.12 Million USD | 7810.938% |
| Clene Inc. | -43.24 Million USD | -813.022% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1615.852% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -714.407% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1380.383% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -31.791% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -974.89% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1774.797% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 8140.316% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1115.442% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -149.236% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 42.306% |
| Evaxion Biotech A/S | -21.4 Million USD | -1744.601% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -494.444% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -81.376% |
| Trevena, Inc. | -35.28 Million USD | -1018.794% |
| Surrozen, Inc. | -41.13 Million USD | -859.86% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -396.03% |
| Cingulate Inc. | -22.95 Million USD | -1620.109% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5191.516% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -958.928% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -4699.2% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -286.052% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -482.069% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -576.352% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4432.376% |
| Kronos Bio, Inc. | -121.83 Million USD | -224.058% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -431.059% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -16070.957% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -291.562% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1113.999% |
| ImmunityBio, Inc. | -436.18 Million USD | 9.487% |
| Korro Bio, Inc. | -80.9 Million USD | -387.986% |
| Kineta, Inc. | -15.71 Million USD | -2412.409% |
| BioVie Inc. | -31.95 Million USD | -1135.673% |
| Codexis, Inc. | -49.28 Million USD | -701.088% |
| Celularity Inc. | -183.94 Million USD | -114.628% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -78.231% |
| Celcuity Inc. | -58.3 Million USD | -577.071% |
| Virax Biolabs Group Limited | -6.6 Million USD | -5873.542% |
| Cibus, Inc. | -314.58 Million USD | -25.499% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1070.367% |
| IN8bio, Inc. | -28.5 Million USD | -1285.069% |
| Kodiak Sciences Inc. | -259.02 Million USD | -52.419% |
| Annexon, Inc. | -141.57 Million USD | -178.863% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -250.625% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -514.992% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1312.27% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -71.645% |
| Eyenovia, Inc. | -24.1 Million USD | -1537.764% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 981.565% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -121751.852% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -434.93% |
| Arcellx, Inc. | -64.14 Million USD | -515.481% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -777.06% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -219.738% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1178.415% |
| Moolec Science SA | -52.07 Million USD | -658.129% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -665.027% |
| Geron Corporation | -174.78 Million USD | -125.881% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -876.817% |
| Royalty Pharma plc | 1.88 Billion USD | 120.919% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -230.12% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4134.119% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1803.499% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -137.717% |
| Humacyte, Inc. | -96.45 Million USD | -309.297% |
| Structure Therapeutics Inc. | -102.45 Million USD | -285.325% |
| 89bio, Inc. | -134.46 Million USD | -193.612% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -400.539% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 9843.337% |
| Genelux Corporation | -24.16 Million USD | -1533.768% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1068.047% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -141.521% |
| Notable Labs, Ltd. | -14.4 Million USD | -2641.667% |
| Liquidia Corporation | -70.05 Million USD | -463.589% |
| Mustang Bio, Inc. | -48.06 Million USD | -721.422% |
| Immunovant, Inc. | -269.97 Million USD | -46.234% |
| Quantum-Si incorporated | -91.8 Million USD | -330.047% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -456.166% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1944.748% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -287.013% |
| Acasti Pharma Inc. | -11.3 Million USD | -3393.496% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1674.124% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2475.19% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -87.542% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -9145.159% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2386.146% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1271.977% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -966.163% |
| PepGen Inc. | -83.58 Million USD | -372.351% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1238.124% |
| United Therapeutics Corporation | 1.38 Billion USD | 128.468% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1624.243% |
| Solid Biosciences Inc. | -93.43 Million USD | -322.544% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -8173.718% |
| Immuneering Corporation | -58.06 Million USD | -579.977% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 12310670.627% |
| Silo Pharma, Inc. | -3.62 Million USD | -10787.388% |
| Belite Bio, Inc | -31.52 Million USD | -1152.181% |
| XOMA Corporation | -39.36 Million USD | -902.998% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -485.348% |
| Bionomics Limited | -9.83 Million USD | -3913.421% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -370.084% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1040.843% |
| uniQure N.V. | -253.1 Million USD | -55.986% |
| Cassava Sciences, Inc. | -95.68 Million USD | -312.595% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5300.748% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -204.855% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1115.63% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4804.06% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1299.057% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -121751.852% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3443.668% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2382.863% |
| Altimmune, Inc. | -87.93 Million USD | -348.968% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -328.762% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1040.843% |
| Compugen Ltd. | -12.51 Million USD | -3054.362% |
| Peak Bio, Inc. | -1356.23 USD | -29110006.693% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -712.379% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1655.447% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -62.936% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1283.176% |
| Zura Bio Limited | -60.56 Million USD | -551.883% |
| PolyPid Ltd. | -20.26 Million USD | -1848.379% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2428.662% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1283.176% |
| Instil Bio, Inc. | -146.12 Million USD | -170.185% |
| argenx SE | -216.02 Million USD | -82.758% |
| Immunome, Inc. | -28.27 Million USD | -1296.484% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -714.474% |
| Verona Pharma plc | -52.46 Million USD | -652.465% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -316.579% |
| Shattuck Labs, Inc. | -87.61 Million USD | -350.608% |
| CervoMed Inc. | -2.17 Million USD | -18077.85% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -222.961% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3010.376% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -719.529% |
| Moolec Science SA | -52.07 Million USD | -658.129% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2203.386% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -202.782% |
| AnaptysBio, Inc. | -143.16 Million USD | -175.768% |
| Design Therapeutics, Inc. | -66.32 Million USD | -495.251% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -387.486% |
| NeurAxis, Inc. | -6.66 Million USD | -5823.93% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -945.828% |
| Lumos Pharma, Inc. | -36.57 Million USD | -979.573% |
| Achilles Therapeutics plc | -70.44 Million USD | -460.461% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -316.579% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1683.679% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 6872.744% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -16070.957% |
| Nutriband Inc. | -5.12 Million USD | -7608.262% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -259.733% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -612.224% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -681.009% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -504.807% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -629.626% |
| Palisade Bio, Inc. | -12.28 Million USD | -3114.722% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -770.063% |
| Beam Therapeutics Inc. | -156.47 Million USD | -152.312% |
| Neurogene Inc. | -52.28 Million USD | -655.078% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -189.252% |
| AEON Biopharma, Inc. | -48.36 Million USD | -716.36% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -324.434% |
| Sesen Bio, Inc. | -50.84 Million USD | -676.554% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -381.863% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3096.755% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 7.634% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -275.296% |
| Athira Pharma, Inc. | -116.7 Million USD | -238.295% |
| Vaccinex, Inc. | -19.74 Million USD | -1899.19% |
| HCW Biologics Inc. | -23.57 Million USD | -1574.58% |
| XOMA Corporation | -39.36 Million USD | -902.998% |
| Nektar Therapeutics | -243.1 Million USD | -62.398% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 209314.333% |
| Merus N.V. | -149.2 Million USD | -164.599% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -322.291% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1162.956% |
| Rezolute, Inc. | -68.42 Million USD | -476.999% |
| Clene Inc. | -43.24 Million USD | -813.022% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2459.948% |
| BeyondSpring Inc. | -21.54 Million USD | -1732.869% |
| Synlogic, Inc. | -55.16 Million USD | -615.723% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3167.4% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3609.829% |
| Peak Bio, Inc. | -1356.23 USD | -29110006.693% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1116.079% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2305.094% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -233.381% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -15.66% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -8470.625% |
| MannKind Corporation | 15.12 Million USD | 2709.558% |
| Ikena Oncology, Inc. | -74.39 Million USD | -430.667% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3035.075% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2042.244% |
| Gossamer Bio, Inc. | -172.15 Million USD | -129.332% |
| CohBar, Inc. | -12.06 Million USD | -3172.069% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1447.689% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1214.904% |
| Legend Biotech Corporation | -477.87 Million USD | 17.384% |
| Mural Oncology plc | -192.72 Million USD | -104.857% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -246.152% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2345.298% |
| Disc Medicine, Inc. | -91.02 Million USD | -333.727% |
| Champions Oncology, Inc. | -5.05 Million USD | -7711.634% |
| REGENXBIO Inc. | -239.46 Million USD | -64.868% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3583.459% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -608.085% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -918.359% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -249.981% |
| Vaxart, Inc. | -74.72 Million USD | -428.351% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1021.327% |
| Cellectis S.A. | -98.09 Million USD | -302.467% |
| Longeveron Inc. | -20.06 Million USD | -1868.096% |
| Repare Therapeutics Inc. | -114.27 Million USD | -245.488% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 10.108% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -427.723% |
| Revolution Medicines, Inc. | -430.58 Million USD | 8.31% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6177.628% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1182.276% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -429.293% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 8152.213% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3500.547% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 108.573% |
| Denali Therapeutics Inc. | -179.97 Million USD | -119.366% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -414571.036% |
| Veru Inc. | -89.97 Million USD | -338.786% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1368.859% |
| Cingulate Inc. | -22.95 Million USD | -1620.109% |
| Passage Bio, Inc. | -98.34 Million USD | -301.46% |
| Context Therapeutics Inc. | -25.06 Million USD | -1475.383% |
| Exicure, Inc. | -15.53 Million USD | -2440.704% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -91.591% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -967.72% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -6521.277% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -134.353% |
| Nuvalent, Inc. | -149.49 Million USD | -164.094% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -4754.646% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -359.636% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1208.238% |
| OmniAb, Inc. | -49.73 Million USD | -693.871% |
| Anew Medical, Inc. | -1.3 Million USD | -30249.62% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3093.141% |
| Lipocine Inc. | -16.32 Million USD | -2318.723% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -492.17% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -431.338% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -935.318% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -911.944% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1679.741% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 27.569% |
| Ocugen, Inc. | -64.82 Million USD | -509.006% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -326.488% |
| Q32 Bio Inc. | -86.5 Million USD | -356.406% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2232.368% |
| Alumis Inc. Common Stock | -156.89 Million USD | -151.641% |
| Equillium, Inc. | -12.13 Million USD | -3152.595% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -575.195% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4895.351% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1993.211% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -745.541% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -271.245% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2107.24% |
| Dominari Holdings Inc. | -22.44 Million USD | -1659.358% |
| Edesa Biotech, Inc. | -8.19 Million USD | -4720.429% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1453.597% |
| Bio-Techne Corporation | 326.66 Million USD | 220.858% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -2.582% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 282.449% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -201.126% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -954.741% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -161.282% |
| Nkarta, Inc. | -120.48 Million USD | -227.687% |
| BioCardia, Inc. | -11.56 Million USD | -3315.225% |
| Iterum Therapeutics plc | -34.58 Million USD | -1041.7% |